By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...

Kathy Wylde, the head of the Partnership for New York City, lost the support of the high-powered CEOs who make up the ...

It's still unclear if all patients, particularly those with insurance coverage, will see more cost savings from using that ...

Both products can be used in the UK to provide protection against RSV disease in certain settings. Abrysvo was cleared for ...

A U.K. marketing watchdog has sanctioned Sanofi after ruling its CEO Paul Hudson may have undermined the U.K. government’s ...

UK regulators ruled Sanofi breached industry rules over RSV claims in a newspaper interview, following a complaint from ...

By Michael Erman Feb 5 (Reuters) - Bristol Myers Squibb on Thursday forecast 2026 results above Wall Street estimates, saying ...

NEW YORK (AP) — The Trump administration on Thursday will launch TrumpRx, a website it says will help patients buy ...

Geoff Meacham, Citi Research head of U.S. pharmaceuticals and biotechnology, joins 'Squawk Box' to break down the quarterly ...

Sanofi was criticized by a U.K. trade group, which accused it of making misleading claims about its RSV vaccine and ...

The pharma company had to scale vaccine production from 200 million annually to 3 billion at the pandemic's peak.

Feb 2 (Reuters) - Sanofi has breached the UK pharma code of practice with unsubstantiated claims that its Beyfortus was more ...